Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484153
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-24
Brief Title:
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMRMSS Colorectal Carcinoma
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Conditions & Keywords Data
Conditions:
| Name |
|---|
| To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma |
| To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer |
| Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer |
Keywords:
| Name | View |
|---|---|
| Pirfenidonetumor microenvironment PD-1 antibody | View |